Treatment of choice in recurrent epistaxis in a patient with hereditary hemotelangietasis:
**Core Concept**
Hereditary hemotelangiectasia (HHT) is a genetic disorder characterized by the presence of multiple telangiectasias and arteriovenous malformations (AVMs) throughout the body, including the nasal cavity. The treatment of recurrent epistaxis in HHT patients requires a different approach compared to idiopathic epistaxis, as the underlying pathophysiology is related to the abnormal vascular structure.
**Why the Correct Answer is Right**
The treatment of choice in recurrent epistaxis in HHT patients involves embolization of the AVMs or telangiectasias, which can be achieved through interventional radiology procedures. This approach is more effective than traditional methods such as nasal packing or cauterization, as it directly addresses the underlying vascular abnormality. The correct answer involves the use of embolization materials to occlude the abnormal blood vessels.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not address the underlying vascular abnormality in HHT patients. Nasal packing or cauterization may provide temporary relief but will not prevent future episodes of epistaxis.
**Option B:** This option is incorrect as it is not a specific treatment for HHT-related epistaxis. Systemic medications may be used to manage symptoms but do not address the underlying cause of the bleeding.
**Option C:** This option is incorrect as it is not a suitable treatment for HHT-related epistaxis. Surgical resection of the nasal septum may lead to further complications and is not a recommended approach.
**Clinical Pearl / High-Yield Fact**
In patients with HHT, it is essential to investigate the presence of other systemic manifestations, such as gastrointestinal bleeding or pulmonary AVMs, as part of the diagnostic workup.
**Correct Answer:** C. Embolization of the AVMs or telangiectasias.